Richard D. Truesdell, Jr.

Davis Polk advised the representatives of the several underwriters in connection with the $60 million initial public offering of common stock of Constellation Pharmaceuticals, Inc. The…

Davis Polk advised IHS Markit Ltd. in connection with its SEC-registered offering of $1.25 billion aggregate principal amount of senior notes in two series, consisting of $500 million…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Wix.com Ltd. of $385 million aggregate principal amount of its 0%…

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of Charah Solutions, Inc., which consisted of 7,352,941 shares of…

Davis Polk advised the joint book-running managers in connection with the $172 million public offering of common stock of Deciphera Pharmaceuticals, Inc. The common stock is listed on…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Valero Energy Corporation of $750 million aggregate principal amount of its 4.350% senior notes due…

Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial public offering of 6,150,000 ordinary shares, at $13.00 per…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 4,057,500 shares of common stock of Calyxt, Inc., including 457,500…

Davis Polk is advising IHS Markit on its $1.855 billion acquisition of Ipreo from private equity funds managed by Blackstone and the Goldman Sachs Merchant Banking Division. The acquisition…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 5.375% senior notes due 2027 and a concurrent amendment…